You are here

kidney injury

Guard argues new data render primary endpoint miss 'irrelevant,' tripling share price

Fierce Biotech

Tue, 09/19/23 - 10:41 am

Guard Therapeutics

clinical trials

Alloksys fails to stop kidney injury in heart surgery patients, but subgroup spurs phase 3 plans

Fierce Biotech

Thu, 08/24/23 - 10:18 am

AM-Pharma, once a Pfizer takeover target, flunks phase 3 kidney injury trial

Fierce Biotech

Thu, 10/20/22 - 10:35 am

clinical trials

Angion’s kidney transplant dream dies

EP Vantage

Wed, 10/27/21 - 10:52 am

Angion Biomedica